Additionally, our findings are encouraging, but they warrant further investigations to validate and strengthen the mechanisms underlying the synergistic effect of the TAFA + mCHEMO combination in DLBCL cells, especially more deeply investigating the Akt/mTOR pathway. This evidence concerns the gene AKT1 and diffuse large B-cell lymphoma.